nodes	percent_of_prediction	percent_of_DWPC	metapath
Methamphetamine—L-Phenylalanine—TAT—liver cancer	0.0244	0.35	CrCbGaD
Methamphetamine—Pseudoephedrine—IL2—liver cancer	0.0135	0.193	CrCbGaD
Methamphetamine—Dexfenfluramine—CYP2E1—liver cancer	0.00769	0.11	CrCbGaD
Methamphetamine—Pseudoephedrine—TNF—liver cancer	0.00455	0.0652	CrCbGaD
Methamphetamine—Nateglinide—PPARG—liver cancer	0.00447	0.064	CrCbGaD
Methamphetamine—Benzyl alcohol—CYP2E1—liver cancer	0.00357	0.0511	CrCbGaD
Methamphetamine—Benzyl alcohol—CYP1A1—liver cancer	0.00352	0.0504	CrCbGaD
Methamphetamine—Selegiline—CYP2E1—liver cancer	0.00342	0.049	CrCbGaD
Methamphetamine—Phenelzine—CYP2E1—liver cancer	0.00302	0.0432	CrCbGaD
Methamphetamine—Nateglinide—ALB—liver cancer	0.00168	0.0241	CrCbGaD
Methamphetamine—CYP2D6—Metabolism—GSTA1—liver cancer	0.00018	0.000194	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—TGFB1—liver cancer	0.000179	0.000192	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—MTHFR—liver cancer	0.000179	0.000192	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—HMOX1—liver cancer	0.000179	0.000192	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—CYP2E1—liver cancer	0.000178	0.000192	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—NAT2—liver cancer	0.000178	0.000192	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—PIK3CD—liver cancer	0.000178	0.000191	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—ALB—liver cancer	0.000176	0.000189	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PPARA—liver cancer	0.000175	0.000189	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—PIK3CG—liver cancer	0.000175	0.000188	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—IL2—liver cancer	0.000174	0.000187	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—HRAS—liver cancer	0.000174	0.000187	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—ADAM17—liver cancer	0.000173	0.000186	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ALDOB—liver cancer	0.000171	0.000184	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—PIK3CD—liver cancer	0.000169	0.000182	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—TGFB1—liver cancer	0.000167	0.00018	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—CYCS—liver cancer	0.000167	0.000179	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PRKCE—liver cancer	0.000166	0.000179	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—GSTM1—liver cancer	0.000166	0.000179	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—IL6—liver cancer	0.000166	0.000179	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—KRAS—liver cancer	0.000166	0.000178	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—PIK3CD—liver cancer	0.000165	0.000177	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—GGT1—liver cancer	0.000164	0.000176	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—GOT1—liver cancer	0.000164	0.000176	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—F2—liver cancer	0.000163	0.000176	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CRABP1—liver cancer	0.000163	0.000175	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PSMD10—liver cancer	0.000163	0.000175	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PSMA4—liver cancer	0.000163	0.000175	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—PIK3CB—liver cancer	0.000158	0.00017	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—CYP1A1—liver cancer	0.000158	0.00017	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—IGF2—liver cancer	0.000158	0.00017	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—PIK3CG—liver cancer	0.000156	0.000168	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PRKCE—liver cancer	0.000155	0.000167	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—PIK3CB—liver cancer	0.000155	0.000167	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—KRAS—liver cancer	0.000155	0.000167	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—PIK3CD—liver cancer	0.000154	0.000165	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—AKT1—liver cancer	0.000153	0.000165	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—PIK3CA—liver cancer	0.000152	0.000164	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PIK3CG—liver cancer	0.00015	0.000161	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—F2—liver cancer	0.000148	0.00016	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—VEGFA—liver cancer	0.000148	0.000159	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—PIK3CB—liver cancer	0.000148	0.000159	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—TP53—liver cancer	0.000147	0.000158	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—IGF2—liver cancer	0.000147	0.000158	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CSF2—liver cancer	0.000147	0.000158	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—GSTP1—liver cancer	0.000147	0.000158	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—MTHFR—liver cancer	0.000147	0.000158	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—RAF1—liver cancer	0.000147	0.000158	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—H2AFX—liver cancer	0.000145	0.000156	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—IL2—liver cancer	0.000145	0.000156	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—HMOX1—liver cancer	0.000145	0.000156	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PPARG—liver cancer	0.000145	0.000156	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PPARA—liver cancer	0.000144	0.000155	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—PIK3CB—liver cancer	0.000143	0.000154	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—HPGDS—liver cancer	0.000143	0.000153	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—PIK3CA—liver cancer	0.000142	0.000153	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—PIK3CG—liver cancer	0.000142	0.000153	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—HRAS—liver cancer	0.000141	0.000152	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—TP53—liver cancer	0.000138	0.000148	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CSF2—liver cancer	0.000138	0.000148	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—PIK3CD—liver cancer	0.000137	0.000148	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—RAF1—liver cancer	0.000137	0.000148	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—TGFB1—liver cancer	0.000136	0.000146	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—H2AFX—liver cancer	0.000136	0.000146	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—IL2—liver cancer	0.000135	0.000146	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—GSTM1—liver cancer	0.000135	0.000145	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—PIK3CB—liver cancer	0.000134	0.000144	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PIK3CD—liver cancer	0.000132	0.000142	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—IL2—liver cancer	0.000132	0.000142	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—HRAS—liver cancer	0.000132	0.000142	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—TERT—liver cancer	0.000131	0.000141	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—ALB—liver cancer	0.00013	0.00014	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—CYP1A1—liver cancer	0.000128	0.000138	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PSMA4—liver cancer	0.000127	0.000137	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PSMD10—liver cancer	0.000127	0.000137	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PRKCE—liver cancer	0.000126	0.000136	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—KRAS—liver cancer	0.000126	0.000135	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—PIK3CD—liver cancer	0.000125	0.000134	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—AKT1—liver cancer	0.000124	0.000134	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—GOT2—liver cancer	0.000124	0.000133	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PIK3CG—liver cancer	0.000124	0.000133	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—IL2—liver cancer	0.000123	0.000132	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—TERT—liver cancer	0.000123	0.000132	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—KDR—liver cancer	0.00012	0.000129	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—PIK3CB—liver cancer	0.00012	0.000129	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IGF2—liver cancer	0.00012	0.000129	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—MTHFR—liver cancer	0.000119	0.000128	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—MAPK14—liver cancer	0.000119	0.000128	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PPARG—liver cancer	0.000119	0.000128	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PPARA—liver cancer	0.000117	0.000126	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—ESR1—liver cancer	0.000117	0.000126	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—AKT1—liver cancer	0.000116	0.000125	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CYP2E1—liver cancer	0.000116	0.000125	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—PIK3CA—liver cancer	0.000116	0.000124	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—F2—liver cancer	0.000116	0.000124	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PIK3CB—liver cancer	0.000115	0.000124	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—KDR—liver cancer	0.000112	0.000121	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—TP53—liver cancer	0.000112	0.00012	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—PIK3CA—liver cancer	0.000112	0.00012	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CSF2—liver cancer	0.000112	0.00012	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—RAF1—liver cancer	0.000111	0.00012	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—MAPK14—liver cancer	0.000111	0.00012	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PIK3CG—liver cancer	0.000111	0.000119	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—APC—liver cancer	0.000111	0.000119	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—H2AFX—liver cancer	0.00011	0.000118	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—IL2—liver cancer	0.00011	0.000118	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—ESR1—liver cancer	0.000109	0.000117	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—PIK3CB—liver cancer	0.000109	0.000117	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CYCS—liver cancer	0.000109	0.000117	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PIK3CD—liver cancer	0.000109	0.000117	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—F2—liver cancer	0.000108	0.000116	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—ALB—liver cancer	0.000107	0.000115	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—HRAS—liver cancer	0.000107	0.000115	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—GOT1—liver cancer	0.000107	0.000115	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—GGT1—liver cancer	0.000107	0.000115	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—BRAF—liver cancer	0.000104	0.000112	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—APC—liver cancer	0.000103	0.000111	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PIK3CG—liver cancer	0.000103	0.000111	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PIK3CG—liver cancer	0.0001	0.000108	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—IL2—liver cancer	9.99e-05	0.000107	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—TERT—liver cancer	9.96e-05	0.000107	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PIK3CD—liver cancer	9.72e-05	0.000104	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—BRAF—liver cancer	9.71e-05	0.000104	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PPARG—liver cancer	9.68e-05	0.000104	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—PIK3CA—liver cancer	9.63e-05	0.000104	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—SERPINE1—liver cancer	9.61e-05	0.000103	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—GSTP1—liver cancer	9.58e-05	0.000103	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—KRAS—liver cancer	9.52e-05	0.000102	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PIK3CB—liver cancer	9.46e-05	0.000102	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—PIK3CA—liver cancer	9.46e-05	0.000102	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—HMOX1—liver cancer	9.45e-05	0.000102	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—AKT1—liver cancer	9.44e-05	0.000102	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—AKT1—liver cancer	9.13e-05	9.82e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—KDR—liver cancer	9.11e-05	9.79e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PIK3CD—liver cancer	9.08e-05	9.76e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—MAPK14—liver cancer	9.05e-05	9.73e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—PIK3CA—liver cancer	8.99e-05	9.67e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—SERPINE1—liver cancer	8.98e-05	9.65e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—KRAS—liver cancer	8.89e-05	9.56e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—ESR1—liver cancer	8.87e-05	9.54e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PIK3CD—liver cancer	8.82e-05	9.48e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—GSTM1—liver cancer	8.8e-05	9.47e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—F2—liver cancer	8.77e-05	9.42e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—PIK3CA—liver cancer	8.74e-05	9.4e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—ALB—liver cancer	8.71e-05	9.36e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—RAF1—liver cancer	8.68e-05	9.33e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PIK3CB—liver cancer	8.47e-05	9.11e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—MTOR—liver cancer	8.47e-05	9.11e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—APC—liver cancer	8.39e-05	9.02e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PIK3CG—liver cancer	8.39e-05	9.02e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CYP1A1—liver cancer	8.35e-05	8.97e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—PIK3CA—liver cancer	8.17e-05	8.78e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—RAF1—liver cancer	8.11e-05	8.71e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—HRAS—liver cancer	8.09e-05	8.7e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CDKN1B—liver cancer	7.95e-05	8.55e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—MTOR—liver cancer	7.91e-05	8.51e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PIK3CB—liver cancer	7.91e-05	8.51e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—BRAF—liver cancer	7.89e-05	8.48e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—AKT1—liver cancer	7.86e-05	8.46e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CASP3—liver cancer	7.79e-05	8.38e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—MTHFR—liver cancer	7.78e-05	8.37e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—IL2—liver cancer	7.78e-05	8.36e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—IL6—liver cancer	7.74e-05	8.32e-05	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—AKT1—liver cancer	7.73e-05	8.31e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PIK3CB—liver cancer	7.69e-05	8.26e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PPARA—liver cancer	7.63e-05	8.21e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CCND1—liver cancer	7.58e-05	8.15e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—JUN—liver cancer	7.57e-05	8.14e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—HRAS—liver cancer	7.56e-05	8.12e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CTNNB1—liver cancer	7.51e-05	8.08e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CDKN1B—liver cancer	7.43e-05	7.98e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PIK3CD—liver cancer	7.37e-05	7.93e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—MMP9—liver cancer	7.36e-05	7.92e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—AKT1—liver cancer	7.35e-05	7.9e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CDKN1A—liver cancer	7.34e-05	7.89e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—PIK3CA—liver cancer	7.3e-05	7.85e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—SERPINE1—liver cancer	7.29e-05	7.84e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CASP3—liver cancer	7.28e-05	7.83e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—IL2—liver cancer	7.27e-05	7.81e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—IL6—liver cancer	7.23e-05	7.77e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—KRAS—liver cancer	7.22e-05	7.76e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—MAPK8—liver cancer	7.16e-05	7.7e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—AKT1—liver cancer	7.14e-05	7.68e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CCND1—liver cancer	7.09e-05	7.62e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—JUN—liver cancer	7.07e-05	7.6e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CTNNB1—liver cancer	7.02e-05	7.54e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PIK3CA—liver cancer	7.01e-05	7.54e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—MMP9—liver cancer	6.88e-05	7.4e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CDKN1A—liver cancer	6.85e-05	7.37e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—MAPK8—liver cancer	6.69e-05	7.19e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—AKT1—liver cancer	6.67e-05	7.17e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—PIK3CA—liver cancer	6.63e-05	7.13e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—VEGFA—liver cancer	6.61e-05	7.11e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—RAF1—liver cancer	6.58e-05	7.08e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—STAT3—liver cancer	6.55e-05	7.04e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PIK3CG—liver cancer	6.54e-05	7.03e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—MTOR—liver cancer	6.43e-05	6.91e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PIK3CB—liver cancer	6.43e-05	6.91e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PPARG—liver cancer	6.31e-05	6.78e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—VEGFA—liver cancer	6.18e-05	6.64e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—HRAS—liver cancer	6.14e-05	6.6e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—STAT3—liver cancer	6.12e-05	6.58e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—MYC—liver cancer	6.08e-05	6.54e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—TGFB1—liver cancer	6.07e-05	6.52e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CDKN1B—liver cancer	6.03e-05	6.49e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—AKT1—liver cancer	5.97e-05	6.42e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CASP3—liver cancer	5.91e-05	6.36e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IL2—liver cancer	5.9e-05	6.35e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—IL6—liver cancer	5.87e-05	6.31e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PIK3CA—liver cancer	5.77e-05	6.2e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CCND1—liver cancer	5.75e-05	6.19e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PIK3CD—liver cancer	5.75e-05	6.18e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—JUN—liver cancer	5.74e-05	6.17e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—AKT1—liver cancer	5.73e-05	6.16e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CTNNB1—liver cancer	5.7e-05	6.13e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—MYC—liver cancer	5.68e-05	6.11e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ALB—liver cancer	5.67e-05	6.1e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—TGFB1—liver cancer	5.67e-05	6.09e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—KRAS—liver cancer	5.62e-05	6.04e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—MMP9—liver cancer	5.59e-05	6.01e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CDKN1A—liver cancer	5.57e-05	5.99e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—MAPK8—liver cancer	5.43e-05	5.84e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—AKT1—liver cancer	5.42e-05	5.83e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—KRAS—liver cancer	5.25e-05	5.65e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PIK3CA—liver cancer	5.16e-05	5.55e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—VEGFA—liver cancer	5.02e-05	5.39e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PIK3CB—liver cancer	5.01e-05	5.39e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—TP53—liver cancer	5e-05	5.37e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—STAT3—liver cancer	4.97e-05	5.34e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PIK3CA—liver cancer	4.82e-05	5.19e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—HRAS—liver cancer	4.78e-05	5.14e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—AKT1—liver cancer	4.71e-05	5.07e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PIK3CA—liver cancer	4.69e-05	5.04e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—TP53—liver cancer	4.67e-05	5.02e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—MYC—liver cancer	4.62e-05	4.96e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—TGFB1—liver cancer	4.6e-05	4.95e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—IL6—liver cancer	4.57e-05	4.92e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—HRAS—liver cancer	4.46e-05	4.8e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—IL6—liver cancer	4.27e-05	4.59e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—KRAS—liver cancer	4.27e-05	4.59e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—AKT1—liver cancer	4.22e-05	4.54e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—AKT1—liver cancer	3.94e-05	4.24e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PIK3CA—liver cancer	3.92e-05	4.21e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—AKT1—liver cancer	3.83e-05	4.12e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—TP53—liver cancer	3.79e-05	4.08e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—HRAS—liver cancer	3.63e-05	3.9e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IL6—liver cancer	3.47e-05	3.73e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—AKT1—liver cancer	3.2e-05	3.44e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PIK3CA—liver cancer	3.05e-05	3.28e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—AKT1—liver cancer	2.49e-05	2.68e-05	CbGpPWpGaD
